Answer
Oct 23, 2025 - 11:23 AM
The duration a patient can be on osimertinib, a medication used to treat certain types of non-small cell lung cancer, depends on individual response and tolerance to the treatment. Typically, patients continue taking osimertinib as long as it is effective and the side effects are manageable. It's important for patients to have regular consultations with their healthcare provider to assess the ongoing appropriateness of the treatment.
